window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'UA-48293608-1');
Logo-bi
Original Research COVID-19

1. A domain-based vaccine construct against SARS-CoV-2, the causative agent of COVID-19 pandemic: development of self-amplifying mRNA and peptide vaccines

Mohammad Mostafa Pourseif ORCID, Sepideh Parvizpour, Behzad Jafari, Jaber Dehghani ORCID, Behrouz Naghili, Yadollah Omidi* ORCID
BioImpacts. 2021;11(1): 65-84. doi: 10.34172/bi.2021.11
PMCID: PMC7803919     PMID: 33469510     Scopus ID: 85099197264    
Article
PDF
Suppl 1
Suppl 2
Suppl 3
Full Text
XML
Cited By:
44
25
45
Immunodominant T-cell epitopes of SARS-CoV-2 spike protein with the highest population coverage were predicted by analyzing peptide binders and consensus rank (CR) score. Multi-method B-cell epitope prediction approach was used to find B-cell immunodominant regions of spike protein. Upon the high immune-potent regions of the antigen(s), self-amplifying mRNA and peptide-based vaccines were designed.

Review

2. Promising leads against lung cancer from the plants in Lamiaceae family
Alireza Rahimlouy Aghdam ORCID, Sanaz Hamedeyazdan* ORCID
Bioimpacts. 2025;15: 30074 | Published on: 2024 Jun 08. doi: 10.34172/bi.30074
PMCID: PMC11830130     PMID: 39963559     Scopus ID: 85215865852    
Article
PDF
Full Text
XML
Cited By:
1
0
1
Original Article

3. Immunoinformatics design of an mRNA vaccine against classical swine fever virus using conserved E2 protein and NS3 T-lymphocyte epitopes
Edward C. Banico ORCID, Ella Mae Joy S. Sira ORCID, Lauren Emily Fajardo ORCID, Fredmoore L. Orosco* ORCID
Bioimpacts. 2025;15: 30778 | Published on: 2025 Apr 06. doi: 10.34172/bi.30778
PMCID: PMC12204779     PMID: 40584901     Scopus ID: 105002125337    
Article
PDF
Full Text
XML
Cited By:
0
0
0
Editorial

4.

Exaggerating the risks of vaccination is a dangerous health threat
Robert C. Speth* ORCID
Bioimpacts. 2026;16: 33132 | Published on: 2026 Jan 05. doi: 10.34172/bi.33132
Article
PDF
XML
Cited By:
0
0
0

Poster

As a peer-reviewed international open-access journal, BioImpacts publishes articles on basic and translational aspects of pharmaceutical and biomedical sciences. 
Acceptance rate (2024): 20% 
Publication fee: Free of charge

Indexing/Abstracting Info
PubMed; PubMed Central; Scopus; Science Citation Index Expanded; Google Scholar;   SJR; Essential Science Indicators; Embase; EBSCOhost; CAS: DOAJ: SHERPA/RoMEO
Member of   
Follower of ICMJE
Permission: Creative Commons